nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An Example of an Unblinded, Third-Party Interim Analysis for Sample Size Re-estimation
|
Kirby, Simon |
|
|
37 |
3 |
p. 317-320 |
artikel |
2 |
A Primer on Bioterrorism: Potential Pathogens, Roles of United States Governmental Agencies, and Regulatory Models for Product Development
|
Dovenport, Colleen M. |
|
|
37 |
3 |
p. 341-352 |
artikel |
3 |
Development of a Patient Recruitment Program for Phase 2 Trials in a Biotechnology Company
|
Fung, Stacey M. |
|
|
37 |
3 |
p. 259-270 |
artikel |
4 |
Efficiency of General Estimating Equations Estimators of Slopes in Repeated Measurements: Adding Subjects or Adding Measurements?
|
Ahn, Chul |
|
|
37 |
3 |
p. 309-316 |
artikel |
5 |
Erratum to: Modeling the probability-cost-profitability architecture of portfolio management in the pharmaceutical industry
|
Zipfel, Andreas |
|
|
37 |
3 |
p. 328 |
artikel |
6 |
Feasibility of Using the Med-eMonitor System in the Treatment of Schizophrenia: A Pilot Study
|
Ruskin, Paul E. |
|
|
37 |
3 |
p. 283-291 |
artikel |
7 |
Impact of Disease Management on Cost-Effectiveness of Medicare Spending
|
Cohen, Joshua |
|
|
37 |
3 |
p. 329-339 |
artikel |
8 |
New DIA Program: Clinical Investigator Education, Training, and Certification
|
Sherman, Jeffrey W. |
|
|
37 |
3 |
p. 257-258 |
artikel |
9 |
The Clinical Data Interchange Standards Consortium Laboratory Model: Standardizing Laboratory Data Interchange in Clinical Trials
|
Bassion, Susan |
|
|
37 |
3 |
p. 271-281 |
artikel |
10 |
The New European Union Good Agricultural and Collection Practice Rules: Are Good Practices Good Enough if They Do Not Result in Batch-to-Batch Consistency?
|
Scholten, Willem K. |
|
|
37 |
3 |
p. 321-327 |
artikel |
11 |
The Pursuit of Balance Using Stratified and Dynamic Randomization Techniques: An Overview
|
McEntegart, Damian J. |
|
|
37 |
3 |
p. 293-308 |
artikel |